{"title":"鼻出血的触发因素及处理的回顾性研究-我们在三级耳鼻喉科诊所的经验。","authors":"Raluca Oana Pulpă, Ruxandra Oana Aliuș, Andreea Rusescu, Irina-Gabriela Ioniță, Răzvan Hainăroșie, Cătălina Voiosu, Viorel Zainea","doi":"10.25122/jml-2025-0107","DOIUrl":null,"url":null,"abstract":"<p><p>Epistaxis is one of the most frequent ENT emergencies, with complex etiologies ranging from local trauma to systemic conditions. This retrospective study analyzed 1,173 patients who presented with epistaxis at a tertiary ENT center over 5 years. Of these, 260 required admissions. The most common triggering factors were hypertension, anticoagulant/antiaggregant therapy, and postoperative complications. A significant portion (38.46%) of cases were idiopathic. Recurrent bleeding was often associated with high blood pressure and male gender, particularly in the 61-70-year age group. Hereditary hemorrhagic telangiectasia was diagnosed in 11 patients, all requiring repeated interventions. Most anterior nasal bleedings had a good response to conservative measures. Posterior or severe cases of epistaxis may require surgical interventions such as cauterization or argon plasma coagulation. The purpose of this paper is to highlight the importance of individualized management, taking into account the location, etiology, and severity. Proper control of cardiovascular comorbidities and careful postoperative monitoring are essential to reducing recurrence and complications associated with epistaxis.</p>","PeriodicalId":16386,"journal":{"name":"Journal of Medicine and Life","volume":"18 8","pages":"759-765"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467489/pdf/","citationCount":"0","resultStr":"{\"title\":\"A retrospective study on triggering factors and management of epistaxis - our experience in a tertiary ENT clinic.\",\"authors\":\"Raluca Oana Pulpă, Ruxandra Oana Aliuș, Andreea Rusescu, Irina-Gabriela Ioniță, Răzvan Hainăroșie, Cătălina Voiosu, Viorel Zainea\",\"doi\":\"10.25122/jml-2025-0107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Epistaxis is one of the most frequent ENT emergencies, with complex etiologies ranging from local trauma to systemic conditions. This retrospective study analyzed 1,173 patients who presented with epistaxis at a tertiary ENT center over 5 years. Of these, 260 required admissions. The most common triggering factors were hypertension, anticoagulant/antiaggregant therapy, and postoperative complications. A significant portion (38.46%) of cases were idiopathic. Recurrent bleeding was often associated with high blood pressure and male gender, particularly in the 61-70-year age group. Hereditary hemorrhagic telangiectasia was diagnosed in 11 patients, all requiring repeated interventions. Most anterior nasal bleedings had a good response to conservative measures. Posterior or severe cases of epistaxis may require surgical interventions such as cauterization or argon plasma coagulation. The purpose of this paper is to highlight the importance of individualized management, taking into account the location, etiology, and severity. Proper control of cardiovascular comorbidities and careful postoperative monitoring are essential to reducing recurrence and complications associated with epistaxis.</p>\",\"PeriodicalId\":16386,\"journal\":{\"name\":\"Journal of Medicine and Life\",\"volume\":\"18 8\",\"pages\":\"759-765\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467489/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicine and Life\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25122/jml-2025-0107\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicine and Life","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25122/jml-2025-0107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
A retrospective study on triggering factors and management of epistaxis - our experience in a tertiary ENT clinic.
Epistaxis is one of the most frequent ENT emergencies, with complex etiologies ranging from local trauma to systemic conditions. This retrospective study analyzed 1,173 patients who presented with epistaxis at a tertiary ENT center over 5 years. Of these, 260 required admissions. The most common triggering factors were hypertension, anticoagulant/antiaggregant therapy, and postoperative complications. A significant portion (38.46%) of cases were idiopathic. Recurrent bleeding was often associated with high blood pressure and male gender, particularly in the 61-70-year age group. Hereditary hemorrhagic telangiectasia was diagnosed in 11 patients, all requiring repeated interventions. Most anterior nasal bleedings had a good response to conservative measures. Posterior or severe cases of epistaxis may require surgical interventions such as cauterization or argon plasma coagulation. The purpose of this paper is to highlight the importance of individualized management, taking into account the location, etiology, and severity. Proper control of cardiovascular comorbidities and careful postoperative monitoring are essential to reducing recurrence and complications associated with epistaxis.
期刊介绍:
The Journal of Medicine and Life publishes peer-reviewed articles from various fields of medicine and life sciences, including original research, systematic reviews, special reports, case presentations, major medical breakthroughs and letters to the editor. The Journal focuses on current matters that lie at the intersection of biomedical science and clinical practice and strives to present this information to inform health care delivery and improve patient outcomes. Papers addressing topics such as neuroprotection, neurorehabilitation, neuroplasticity, and neuroregeneration are particularly encouraged, as part of the Journal''s continuous interest in neuroscience research. The Editorial Board of the Journal of Medicine and Life is open to consider manuscripts from all levels of research and areas of biological sciences, including fundamental, experimental or clinical research and matters of public health. As part of our pledge to promote an educational and community-building environment, our issues feature sections designated to informing our readers regarding exciting international congresses, teaching courses and relevant institutional-level events.